Biographies

E-mail this page

(All fields required)

Recipient's email address

Please enter a valid email.

Your name

Please enter your name.

Your email address

Please enter a valid email.

Find another Doctor or Researcher

High Res

Mounira A. Habli

Maternal Fetal Medicine Specialist, Fetal Care Center of Cincinnati

Assistant Director of Clinical Research, Good Samaritan Hospital

Obstetrics and Gynecology, Good Samaritan Hospital

Assistant Professor, Division of Pediatric Surgery

Fax: 513-636-2735

Email: mounira.habli@cchmc.org

Show All

Specialties

Modification of the Wigglesworth model of Intrauterine growth restriction in mice as the animal model; invitro assessment of Insulin like growth factors and adenoviral associated gene expression of insulin like growth factor-I in a rat trophoblast cell line (RCHO-1)

Education and Training

BS: Biology, American University of Beirut, Beirut Lebanon.

MS: Masters Clinical Epidemiology and Biostatistics, Translational Research, University of Cincinnati, Cincinnati, Ohio, 2010.

MD: American University of Beirut, Beirut, Lebanon, 1998.

MFM: University of Cincinnati Maternal Fetal Medicine, 2009.

Publications

View PubMed Publications

Pizarro D, Habli M, Grier M, Bombrys A, Sibai B, Livingston J. Higher maternal doses of methadone does not increase neonatal abstinence syndrome. J Subst Abuse Treat. 2011 Jan 19.

Keswani SG, Le LD, Morris LM, Lim FY, Katz AB, Ghobril N, Habli M, Frischer JS, Crombleholme TM. Submucosal gland development in the human fetal trachea xenograft model: implications for fetal gene therapy. J Pediatr Surg. 2011 Jan;46(1):33-8.

Crombleholme TM, Lim FY, Habli M, Polzin W, Jaekle R, Michelfelder E, Cnota J, Liu C, Kim MO. Improved recipient survival with maternal nifedipine in twin-twin transfusion syndrome complicated by TTTS cardiomyopathy undergoing selective fetoscopic laser photocoagulation. Am J Obstet Gynecol. 2010 Oct;203(4):397.e1-9.

Habli M, Cnota J, Michelfelder E, Salisbury S, Schnell B, Polzin W, Lim FY, Crombleholme TM. The relationship between amniotic fluid levels of brain-type natriuretic peptide and recipient cardiomyopathy in twin-twin transfusion syndrome. Am J Obstet Gynecol. 2010 Oct;203(4):404.e1-7.

Habli M, Bombrys A, Lewis D, Lim FY, Polzin W, Maxwell R, Crombleholme T. Incidence of complications in twin-twin transfusion syndrome after selective fetoscopic laser photocoagulation: a single-center experience. Am J Obstet Gynecol. 2009 Oct;201(4):417.e1-7.

Habli M, Eftekhari N, Wiebracht E, Bombrys A, Khabbaz M, How H, Sibai B. Long-term maternal and subsequent pregnancy outcomes 5 years after hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome. Am J Obstet Gynecol. 2009 Oct;201(4):385.e1-5.

Katz AB, Keswani SG, Habli M, Lim FY, Zoltick PW, Midrio P, Kozin ED, Herlyn M, Crombleholme TM. Placental gene transfer: transgene screening in mice for trophic effects on the placenta. Am J Obstet Gynecol. 2009 Nov;201(5):499.e1-8

Habli M, Lim FY, Crombleholme T. Twin-to-twin transfusion syndrome: a comprehensive update. Clin Perinatol. 2009 Jun;36(2):391-416, x. Review.

Bombrys AE, Barton JR, Habli M, Sibai BM. Expectant management of severe preeclampsia at 27(0/7) to 33(6/7) weeks' gestation: maternal and perinatal outcomes according to gestational age by weeks at onset of expectant management. Am J Perinatol. 2009 Jun;26(6):441-6.

Lubow JM, How HY, Habli M, Maxwell R, Sibai BM. Indications for delivery and short-term neonatal outcomes in late preterm as compared with term births. Am J Obstet Gynecol. 2009 May;200(5):e30-3.